A helmet with infrared light that can heal brain after mild head injury or concussion. This therapy is called Photobiomodulation.

Mild traumatic brain injuries, such as concussions, account for 75% of all cases in the U.S.

Acceleration and deceleration within the cranial vault leads to tearing and stretching of nerve fibers. Alteration of ionic balance and mitochondrial dysfunction makes it difficult for the cells to function while also limiting energy available for healing.

This wearable technology uses light therapy to speed brain recovery. This helmet emits near-infrared light. The light will penetrate the skull and reverse the impaired cellular metabolism that characterizes concussions.

This device can be used in an outpatient setting.

#Concussion
#Traumatic #Head #Injury



Research Paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927185/
Read More: https://www.concussionalliance.org/light-therapy-photobiomodulation 

5/23/2020 03:01:00 PM

• This decision marks a milestone in the convergence of technology and health care.
• The so-called digital pill is a version of Otsuka Pharmaceutical Co.’s Abilify, which treats depression, bipolar disorder and schizophrenia. 
• The sensor, developed by Proteus Digital Health, is activated by stomach fluids, sending a signal to a patch worn on the patient’s torso and transmitting the information to a smartphone app
• It has been approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults, the FDA said.
• The Abilify MyCite features a sensor the size of a grain of sand made of silicon, copper, and magnesium. 
• An electrical signal is activated when the sensor comes into contact with stomach acid — the sensor then passes through the body naturally. 
• A patch the patient wears on their left rib cage receives the signal several minutes after the pill is ingested. 

Read more related posts

FDA ADVISES RESTRICTION IN PRESCRIPTION OF SYSTEMIC FLUOROQUINOLONES FOR THE TREATMENT OF UNCOMPLICATED URIS AND UTIS

http://www.worldsurgeryforum.net/2017/10/fda-advises-restriction-in-prescription.html

CEFTRIAXONE - RINGER LACTATE'S DEADLY INTERACTION

http://www.worldsurgeryforum.net/2017/09/ceftriaxone-ringer-lactates-deadly.html

11/14/2017 08:39:00 PM